[{"arm_notes": "", "treatment_id": null, "treatment_name": "All patients will receive a booster Pfizer-BioNTech COVID-19 vaccine and be tested the immune response at day 15 after vaccination. If the anti-RBD Ig (Abbott Diagnostics; Abbott Park; Ill) is not reached the level of 2;36o BAU/mL; the patients will receive another booster Pfizer-BioNTech COVID-19 vaccine and measure the immune response at day 15 after vaccination. All the patients will be tested the immune response at 3 months and 6 months following the last booster COVID-19 vaccine.;Experimental Biological/Vaccine;Booster", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "have been vaccinated with either inactivated SARS-CoV-2 or viral-vector ChAdOx1 nCoV-19 COVID-19 vaccine", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "All patients will receive a booster Pfizer-BioNTech COVID-19 vaccine and be tested the immune response at day 15 after vaccination. If the anti-RBD Ig (by Roche Elecys) is not reached the level of 2;36o BAU/mL; the patients will receive another booster Pfizer-BioNTech COVID-19 vaccine and measure the immune response at day 15 after vaccination. All the patients will be tested the immune response at 3 months and 6 months following the last booster COVID-19 vaccine.;Experimental Biological/Vaccine;Booster", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]